Related Experiment Video
Updated: Sep 18, 2026

Quantitative Measurement of GLUT4 Translocation to the Plasma Membrane by Flow Cytometry
Published on: November 7, 2010
Glucose transporter type1 (GLUT-1) deficiency
Neil Gordon1, Richard W Newton
1Huntlywood, 3 Styal Road, Wilmslow SK9 4AE, UK. neil-gordon@doctors.org.uk
Insights
Glucose transporter type 1 (GLUT-1) deficiency is a rare but preventable cause of learning difficulties. Early diagnosis is crucial, especially with infantile seizures, developmental delay, and low cerebrospinal fluid glucose levels.
Area of Science:
- Neuroscience
- Genetics
- Metabolic Disorders
Background:
- Glucose transporter type 1 (GLUT-1) deficiency is a rare condition.
- It can lead to severe learning difficulties and developmental delays.
- Early diagnosis is critical for effective management.
Purpose of the Study:
- To highlight the importance of early diagnosis of GLUT-1 deficiency.
- To outline the key diagnostic indicators and genetic basis.
- To discuss management strategies and substances to avoid.
Main Methods:
- Clinical observation of infantile seizures, microcephaly, and developmental delay.
- Biochemical analysis of cerebrospinal fluid (CSF) and blood glucose levels.
- Genetic analysis of the GLUT-1 gene on chromosome 1.
Main Results:
- Low CSF glucose levels differentiate GLUT-1 deficiency from other conditions.
- The condition is linked to heterozygous mutations in the GLUT-1 gene.
- Impaired glucose transport across the blood-brain barrier is central to the pathology.
Conclusions:
- GLUT-1 deficiency requires prompt diagnosis based on clinical and biochemical findings.
- Management involves anti-epileptic drugs, ketogenic diet, and avoidance of inhibitors like caffeine.
- Understanding GLUT-1's role in brain glucose supply is vital for neurological health.
Abstract:
Glucose transporter type1 (GLUT-1) deficiency may be rare, but it is a preventable cause of severe learning difficulties; and therefore there is an urgency in making an early diagnosis. Suspicions must be roused when intractable seizures occur in infancy. These may be associated with acquired microcephaly and developmental delay. The finding of low glucose sugar levels in the cerebrospinal fluid, but not in the blood will identify the condition. The gene encoding the GLUT-1 protein is located on the short arm of chromosome 1, and inheritance is by a dominant trait. Patients with this syndrome can have heterozygous mutations, with one allele being a normal wild type and one being mutant. An efficient transport of glucose across the blood-brain barrier is essential as it is such an important fuel for the brain, and this is provided by glucose transporter type1 in the endothelial cells of the brain capillaries. Another minor contribution to the symptomatology of GLUT-1 may be impaired transport of an oxidised form of vitamin C. Treatment with anti-epileptic drugs may be needed, and the ketogenic diet may reduce symptoms, as ketosis can provide an alternative source of fuel for the brain. It has also been suggested that antioxidant thioctic acid may be of benefit. Substances such as caffeine and phenobarbitone should be avoided as they inhibit glucose transport.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Secondary Active Transport
Secondary Active Transport
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

